Article Details

Neurana Pharmaceuticals Announces Top-Line Results from Tolperisone Phase 1 CNS Effects Study

Retrieved on: 2020-12-08 19:41:15

Tags for this article:

Click the tags to see associated articles and topics

Neurana Pharmaceuticals Announces Top-Line Results from Tolperisone Phase 1 CNS Effects Study. View article details on hiswai:

Excerpt

8, 2020 /PRNewswire/ -- Neurana Pharmaceuticals, a <b>biotechnology</b> company focused on the treatment of neuromuscular conditions, today ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up